| Line 104: | Line 104: | ||
===2017: [https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-017-0676-9 Electronic cigarette vapor alters the lateral structure but not tensiometric properties of calf lung surfactant]=== | ===2017: [https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-017-0676-9 Electronic cigarette vapor alters the lateral structure but not tensiometric properties of calf lung surfactant]=== | ||
*While both e-cigarette vapor and conventional cigarette smoke affect surfactant lateral structure, only cigarette smoke disrupts surfactant interfacial properties. The surfactant inhibitory compound in conventional cigarettes is tar, which is a product of burning and is thus absent in e-cigarette vapor. | *While both e-cigarette vapor and conventional cigarette smoke affect surfactant lateral structure, only cigarette smoke disrupts surfactant interfacial properties. The surfactant inhibitory compound in conventional cigarettes is tar, which is a product of burning and is thus absent in e-cigarette vapor. | ||
===2016: [https://www.omicsonline.org/open-access/changes-in-the-frequency-of-airway-infections-in-smokers-who-switched-to-vaping-results-of-an-online-survey-2155-6105-1000290.pdf Changes in the Frequency of Airway Infections in Smokers Who Switched to Vaping: Results of an Online Survey]=== | ===2016: [https://www.omicsonline.org/open-access/changes-in-the-frequency-of-airway-infections-in-smokers-who-switched-to-vaping-results-of-an-online-survey-2155-6105-1000290.pdf Changes in the Frequency of Airway Infections in Smokers Who Switched to Vaping: Results of an Online Survey]=== | ||
*Results: “Altogether 941 responses were received. Overall, 29% of responders reported no change in respiratory symptoms, 5% reported worsening, and 66% reported an improvement (95% CI=62.9-69.0).” | *Results: “Altogether 941 responses were received. Overall, 29% of responders reported no change in respiratory symptoms, 5% reported worsening, and 66% reported an improvement (95% CI=62.9-69.0).” | ||
===2016: [https://onlinelibrary.wiley.com/doi/abs/10.1111/eci.12651 Changes in breathomics from a 1‐year randomized smoking cessation trial of electronic cigarettes]=== | ===2016: [https://onlinelibrary.wiley.com/doi/abs/10.1111/eci.12651 Changes in breathomics from a 1‐year randomized smoking cessation trial of electronic cigarettes]=== | ||
*Conclusion: “Smokers invited to switch to electronic cigarettes who completely abstained from smoking showed steady progressive improvements in their exhaled breath measurements and symptom scores. FeNo and eCO normalization is highly supportive of improved respiratory health outcomes and adds to the notion that quitting from tobacco smoking can reverse harm in the lung.” | *Conclusion: “Smokers invited to switch to electronic cigarettes who completely abstained from smoking showed steady progressive improvements in their exhaled breath measurements and symptom scores. FeNo and eCO normalization is highly supportive of improved respiratory health outcomes and adds to the notion that quitting from tobacco smoking can reverse harm in the lung.” | ||
===2016: [https://www.omicsonline.org/open-access/changes-in-the-frequency-of-airway-infections-in-smokers-who-switched-to-vaping-results-of-an-online-survey-2155-6105-1000290.php?aid=77944 Changes in the Frequency of Airway Infections in Smokers Who Switched To Vaping: Results of an Online Survey]=== | ===2016: [https://www.omicsonline.org/open-access/changes-in-the-frequency-of-airway-infections-in-smokers-who-switched-to-vaping-results-of-an-online-survey-2155-6105-1000290.php?aid=77944 Changes in the Frequency of Airway Infections in Smokers Who Switched To Vaping: Results of an Online Survey]=== | ||
*The switch from smoking to vaping was associated with a reduced incidence of self-reported respiratory infections. | *The switch from smoking to vaping was associated with a reduced incidence of self-reported respiratory infections. | ||
===2016: [https://pneumonia.biomedcentral.com/articles/10.1186/s41479-016-0001-2 Respiratory infections and pneumonia: potential benefits of switching from smoking to Vaping]=== | ===2016: [https://pneumonia.biomedcentral.com/articles/10.1186/s41479-016-0001-2 Respiratory infections and pneumonia: potential benefits of switching from smoking to Vaping]=== | ||
| Line 126: | Line 118: | ||
*In conclusion, smokers who quit by switching to regular ECs use can reduce risk and reverse harm from tobacco smoking. | *In conclusion, smokers who quit by switching to regular ECs use can reduce risk and reverse harm from tobacco smoking. | ||
*Innovation in the e-vapour category is likely not only to further minimise residual health risks, but also to maximise health benefits. | *Innovation in the e-vapour category is likely not only to further minimise residual health risks, but also to maximise health benefits. | ||
===2014: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053879/ Effect of Smoking Abstinence and Reduction in Asthmatic Smokers Switching to Electronic Cigarettes: Evidence for Harm Reversal]=== | ===2014: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053879/ Effect of Smoking Abstinence and Reduction in Asthmatic Smokers Switching to Electronic Cigarettes: Evidence for Harm Reversal]=== | ||
edits